NSE: NIFTYPHARMA

25674.10 17.85 (0.07%)

New 52W High in past week

NSE 10 Jul, 2026 4:08 PM (IST)

Nifty Pharma PB	5.4
Nifty Pharma PE	39.2
Nifty Pharma DIV	0.6
Nifty Pharma EPS	654

Nifty Pharma News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Glenmark Pharmaceuticals Ltd. authored by Deven Choksey and published by - Trendlyne research reports.
Item: Glenmark Pharmaceuticals Ltd.
Rating: 4
Author: Deven Choksey

Keep track of all breaking news and updates on Nifty Pharma from all sources in a single place.

Load latest

Is Nifty Pharma worth buying?

346 Votes:

Buy 79.19%

Sell 11.85%

Hold 8.96%